XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Oct. 01, 2022
Cash flows from operating activities:    
Net income $ 9,243 $ 58,286
Adjustments to reconcile net income to net cash provided by operating activities:    
Stock-based compensation expense 50,970 1,081
Amortization of debt issuance costs and debt discount 4,631 2,974
Depreciation and amortization 45,088 40,110
Operating lease expense 89,204 86,109
Deferred income taxes, net (3,725) 14,001
Loss on extinguishment of debt 16,626 1,023
Other items (12,714) 34,890
Changes in operating assets and liabilities:    
Trade receivables 341 (9,222)
Inventories (14,227) (6,002)
Prepaid expenses and other current assets 3,675 (10,020)
Accounts payable and accrued liabilities 2,456 4,780
Accrued payroll and related taxes (5,519) (17,026)
Operating lease liabilities (84,081) (82,876)
Other liabilities 2,434 (475)
Net cash provided by operating activities 104,402 117,633
Cash flows from investing activities:    
Purchases of property and equipment (74,579) (80,624)
Purchase of trade name (650) 0
Settlement of derivative instruments, net (199) (774)
Net cash used in investing activities (75,428) (81,398)
Cash flows from financing activities:    
Proceeds from issuance of long-term debt, net 529,247 0
Principal payments on long-term debt (546,431) (8,929)
Payment of debt issuance costs (4,359) (161)
Prepayment premium on extinguishment of debt (1,650) (1,023)
Advances on revolving line of credit 42,000 53,000
Repayments of revolving line of credit (84,000) (53,000)
Dividends paid (262,235) 0
Proceeds from initial public offering, net of underwriting fees 314,719 0
Payment of offering costs (8,766) 0
Repurchase of shares and shares withheld to cover taxes (849) (292)
Settlement of derivative instrument, net 6,213 (1,057)
Net cash used in financing activities (16,111) (11,462)
Effect of exchange rate changes on cash and cash equivalents 312 (6,774)
Net change in cash and cash equivalents 13,175 17,999
Cash and cash equivalents at beginning of period 112,132 97,915
Cash and cash equivalents at end of period 125,307 115,914
Supplemental disclosures of cash flow information:    
Interest paid on debt 70,225 42,715
Income taxes paid, net 10,032 24,839
Supplemental disclosure of noncash investing activities:    
Noncash capital expenditures $ 1,810 $ 4,722